AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 55 filers reported holding AVROBIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $647,918 | +40.3% | 647,918 | 0.0% | 0.17% | +40.0% |
| Q4 2022 | $461,901 | +11.0% | 647,918 | 0.0% | 0.12% | +21.2% |
| Q3 2022 | $416,000 | -30.2% | 647,918 | 0.0% | 0.10% | -40.4% |
| Q2 2022 | $596,000 | -30.3% | 647,918 | 0.0% | 0.17% | -27.5% |
| Q1 2022 | $855,000 | -65.7% | 647,918 | 0.0% | 0.23% | -49.7% |
| Q4 2021 | $2,494,000 | -48.1% | 647,918 | -24.8% | 0.46% | -39.0% |
| Q3 2021 | $4,809,000 | -5.3% | 861,858 | +136.6% | 0.75% | +69.9% |
| Q4 2020 | $5,078,000 | – | 364,285 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |